NCT02278692View on ClinicalTrials.gov

Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
CalciphylaxisCalcific Uremic Arteriolopathy
Interventions
DIETARY_SUPPLEMENT

Vitamin K

Oral vitamin K

OTHER

Placebo

Oral placebo tablet

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Kidney Foundation, United States

OTHER

collaborator

American Heart Association

OTHER

collaborator

Harvard University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02278692 - Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy | Biotech Hunter | Biotech Hunter